Opthea Ltd Files 6-K, Includes Euretina Symposium Press Release
Ticker: OPTEY · Form: 6-K · Filed: Sep 26, 2024 · CIK: 1815620
Sentiment: neutral
Topics: filing, press-release
TL;DR
Opthea filed a 6-K with a press release about Euretina Symposium. CEO signed off.
AI Summary
Opthea Limited filed a Form 6-K on September 26, 2024, reporting on events for the month of September 2024. The filing includes a press release regarding the Euretina Symposium as Exhibit 99.1. Frederic Guerard, CEO, signed the report.
Why It Matters
This filing provides an update on Opthea's activities, specifically highlighting their participation or findings presented at the Euretina Symposium, which could be relevant to their drug development pipeline.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily serves to attach an exhibit, with no new financial or operational disclosures that would inherently increase risk.
Key Players & Entities
- Opthea Limited (company) — Registrant
- Euretina Symposium (event) — Press Release Topic
- Frederic Guerard (person) — Chief Executive Officer
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report on events for the month of September 2024 and to include Exhibit 99.1, which is a Press Release regarding the Euretina Symposium.
Who signed this report on behalf of Opthea Limited?
Frederic Guerard, the Chief Executive Officer of Opthea Limited, signed the report.
What is the Commission File Number for Opthea Limited?
The Commission File Number for Opthea Limited is 001-39621.
What exhibit is included with this Form 6-K filing?
Exhibit 99.1, a Press Release concerning the Euretina Symposium, is included with this Form 6-K filing.
What is the principal executive office address for Opthea Limited?
The principal executive office address for Opthea Limited is Level 4, 650 Chapel Street, South Yarra, Victoria, 3141, Australia.
Filing Stats: 144 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-09-26 06:03:13
Filing Documents
- opt_euretina_symposium.htm (6-K) — 23KB
- opt-ex99_1.htm (EX-99.1) — 59KB
- opt-ex99_1s1.jpg (GRAPHIC) — 265KB
- opt-ex99_1s2.jpg (GRAPHIC) — 148KB
- opt-ex99_1s3.jpg (GRAPHIC) — 418KB
- opt-ex99_1s4.jpg (GRAPHIC) — 338KB
- opt-ex99_1s5.jpg (GRAPHIC) — 216KB
- opt-ex99_1s6.jpg (GRAPHIC) — 315KB
- opt-ex99_1s7.jpg (GRAPHIC) — 327KB
- opt-ex99_1s8.jpg (GRAPHIC) — 157KB
- opt-ex99_1s9.jpg (GRAPHIC) — 187KB
- opt-ex99_1s10.jpg (GRAPHIC) — 166KB
- opt-ex99_1s11.jpg (GRAPHIC) — 355KB
- opt-ex99_1s12.jpg (GRAPHIC) — 269KB
- opt-ex99_1s13.jpg (GRAPHIC) — 557KB
- opt-ex99_1s14.jpg (GRAPHIC) — 284KB
- opt-ex99_1s15.jpg (GRAPHIC) — 482KB
- opt-ex99_1s16.jpg (GRAPHIC) — 400KB
- opt-ex99_1s17.jpg (GRAPHIC) — 252KB
- opt-ex99_1s18.jpg (GRAPHIC) — 308KB
- opt-ex99_1s19.jpg (GRAPHIC) — 258KB
- opt-ex99_1s20.jpg (GRAPHIC) — 242KB
- opt-ex99_1s21.jpg (GRAPHIC) — 416KB
- opt-ex99_1s22.jpg (GRAPHIC) — 313KB
- opt-ex99_1s23.jpg (GRAPHIC) — 180KB
- opt-ex99_1s24.jpg (GRAPHIC) — 139KB
- opt-ex99_1s25.jpg (GRAPHIC) — 164KB
- opt-ex99_1s26.jpg (GRAPHIC) — 401KB
- opt-ex99_1s27.jpg (GRAPHIC) — 388KB
- opt-ex99_1s28.jpg (GRAPHIC) — 225KB
- opt-ex99_1s29.jpg (GRAPHIC) — 414KB
- opt-ex99_1s30.jpg (GRAPHIC) — 387KB
- opt-ex99_1s31.jpg (GRAPHIC) — 369KB
- opt-ex99_1s32.jpg (GRAPHIC) — 346KB
- opt-ex99_1s33.jpg (GRAPHIC) — 363KB
- opt-ex99_1s34.jpg (GRAPHIC) — 315KB
- opt-ex99_1s35.jpg (GRAPHIC) — 327KB
- opt-ex99_1s36.jpg (GRAPHIC) — 236KB
- opt-ex99_1s37.jpg (GRAPHIC) — 197KB
- opt-ex99_1s38.jpg (GRAPHIC) — 135KB
- opt-ex99_1s39.jpg (GRAPHIC) — 138KB
- opt-ex99_1s40.jpg (GRAPHIC) — 398KB
- opt-ex99_1s41.jpg (GRAPHIC) — 338KB
- opt-ex99_1s42.jpg (GRAPHIC) — 260KB
- opt-ex99_1s43.jpg (GRAPHIC) — 269KB
- opt-ex99_1s44.jpg (GRAPHIC) — 238KB
- opt-ex99_1s45.jpg (GRAPHIC) — 372KB
- opt-ex99_1s46.jpg (GRAPHIC) — 376KB
- opt-ex99_1s47.jpg (GRAPHIC) — 244KB
- opt-ex99_1s48.jpg (GRAPHIC) — 304KB
- opt-ex99_1s49.jpg (GRAPHIC) — 302KB
- opt-ex99_1s50.jpg (GRAPHIC) — 275KB
- opt-ex99_1s51.jpg (GRAPHIC) — 441KB
- opt-ex99_1s52.jpg (GRAPHIC) — 366KB
- opt-ex99_1s53.jpg (GRAPHIC) — 122KB
- opt-ex99_1s54.jpg (GRAPHIC) — 445KB
- opt-ex99_1s55.jpg (GRAPHIC) — 324KB
- opt-ex99_1s56.jpg (GRAPHIC) — 443KB
- opt-ex99_1s57.jpg (GRAPHIC) — 334KB
- opt-ex99_1s58.jpg (GRAPHIC) — 323KB
- opt-ex99_1s59.jpg (GRAPHIC) — 314KB
- opt-ex99_1s60.jpg (GRAPHIC) — 135KB
- opt-ex99_1s61.jpg (GRAPHIC) — 277KB
- opt-ex99_1s62.jpg (GRAPHIC) — 434KB
- opt-ex99_1s63.jpg (GRAPHIC) — 384KB
- opt-ex99_1s64.jpg (GRAPHIC) — 259KB
- opt-ex99_1s65.jpg (GRAPHIC) — 411KB
- opt-ex99_1s66.jpg (GRAPHIC) — 128KB
- opt-ex99_1s67.jpg (GRAPHIC) — 145KB
- 0000950170-24-109462.txt ( ) — 27700KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. OPTHEA LIMITED (Registrant) By: /s/ Frederic Guerard Name: Frederic Guerard Title: Chief Executive Officer Date: 09/26/2024